Within its last year performance, ZNTL fell by -23.37%, with highs and lows ranging from $31.46 to $9.56, whereas the simple moving average fell by -25.64% in the last 200 days.
On November 08, 2023, Wedbush Downgraded Zentalis Pharmaceuticals Inc (NASDAQ: ZNTL) to Neutral. A report published by Leerink Partners on November 07, 2023, Downgraded its rating to ‘Market Perform’ for ZNTL. Wells Fargo Initiated an Overweight rating on April 06, 2022, and assigned a price target of $67. Jefferies initiated its ‘Buy’ rating for ZNTL, as published in its report on October 07, 2021. Stifel’s report from September 30, 2021 suggests a price prediction of $84 for ZNTL shares, giving the stock a ‘Buy’ rating. Oppenheimer also rated the stock as ‘Outperform’.
Analysis of Zentalis Pharmaceuticals Inc (ZNTL)
One of the most important indicators of Zentalis Pharmaceuticals Inc’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. The goal here is to ensure that your current return on equity of -67.09% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 7.16, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can also provide valuable insight into volatility, and ZNTL is recording 817.51K average volume. On a monthly basis, the volatility of the stock is set at 7.10%, whereas on a weekly basis, it is put at 7.52%, with a loss of -11.07% over the past seven days. Furthermore, long-term investors anticipate a median target price of $33.56, showing growth from the present price of $13.41, which can serve as yet another indication of whether ZNTL is worth investing in or should be passed over.
How Do You Analyze Zentalis Pharmaceuticals Inc Shares?
Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 10.05%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 109.92% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
ZNTL shares are owned by institutional investors to the tune of 109.92% at present.
